Nebivolol Production Cost Reports

The report provides a detailed analysis essential for establishing a Nebivolol production plant. It encompasses all critical aspects necessary for Nebivolol production, including the cost of Nebivolol production, Nebivolol plant cost, Nebivolol production costs, and the overall Nebivolol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Nebivolol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Nebivolol is an advanced, third-generation beta-1 selective blocker used primarily in the pharmaceutical industry for managing cardiovascular diseases such as hypertension and chronic heart failure. Its unique mechanism combines beta-blockade with nitric oxide-mediated vasodilation, improving endothelial function and reducing vascular resistance, which makes it effective in treating high blood pressure, heart failure, and related vascular conditions.

The major drivers of the nebivolol market include the rising global prevalence of cardiovascular diseases, mainly hypertension, which affects over 1.28 billion adults worldwide. Factors such as increasing healthcare expenditure, expanding elderly populations, and sedentary lifestyles contributing to higher cardiovascular risks also fuel market growth. Nebivolol's advantages, such as selective beta-1 receptor blockade combined with nitric oxide-mediated vasodilation, improve efficacy and tolerability, which makes it a preferred choice among cardiologists.

The growing demand for affordable generic drugs, innovations in drug formulations (including extended-release and combination therapies), and expanding regulatory approvals further boost market expansion. Furthermore, industrial nebivolol procurement is impacted by the availability and cost of raw materials such as 6-Fluoro-4-oxo-4H-1-benzopyran-2-carboxylic acid, which directly impact production costs and supply stability.

Raw Material for Nebivolol Production

According to the Nebivolol production plant project report, the raw material for Nebivolol production includes methyl 6-fluorochromane-2-carboxylate.

Production Process of Nebivolol

The extensive Nebivolol production cost report consists of the following major industrial production process:

1. Production from methyl 6-fluorochromane-2-carboxylate: The production process of (+)-nebivolol initiates with the conversion of methyl 6-fluorochromane-2-carboxylate to a racemic β-keto sulfoxonium ylide, which is then transformed into 2-chloro-1-(6-fluorochroman-2-yl)ethanone. This compound is reduced enzymatically by Ketoreductase into halohydrins, producing separable stereoisomers. The desired halohydrin undergoes amination to form the corresponding amino alcohol, which then reacts with another halohydrin stereoisomer to yield (+)-nebivolol.

Properties of Nebivolol

Nebivolol is a white crystalline powder with a molecular formula of C22H25F2NO4 and a molecular weight of 405.44 g/mol. It is a highly lipophilic compound with a log P value around 3.2 to 4.18, indicating moderate to high lipid solubility. It has two pKa values at about 8.9 and 13.52. Nebivolol is soluble in methanol, dimethyl sulfoxide, and N,N-dimethylformamide, sparingly soluble in ethanol and propylene glycol, and poorly soluble in water, dichloromethane, hexane, and toluene.

It has a melting point in the range of 223–228 degree Celsius. Its hydrochloride salt form is used pharmaceutically to improve solubility and stability. Additionally, physicochemical enhancements such as crystallisation with amino acids have been explored to improve its aqueous solubility and dissolution rate. The compound is stable under recommended storage conditions, in a cool, dry place protected from moisture and light.